Buying Buzz: GeoVax Labs Inc. [GOVX] VP, Business Development Sharkey John W. purchases 1,000 shares of the company

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GeoVax Labs Inc. shares valued at $820 were purchased by Sharkey John W. on Jul 01. At $0.82 per share, Sharkey John W. acquired 1,000 shares. The insider’s holdings grew to 2,860 shares worth approximately $10210.199999999999 following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Also, McKee Kelly T. Jr. purchased 4,464 shares, netting a total of over 5,000 in proceeds. Following the buying of shares at $1.12 each, the insider now holds 19,185 shares.

Before that, CHASE RANDAL D had added 10,000 shares to its account. In a trade valued at $12,100, the Director bought GeoVax Labs Inc. shares for $1.21 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $95008.40999999999.

As published in their initiating research note from Maxim Group on November 19, 2020, GeoVax Labs Inc. [GOVX] has been a Buy and the price target has been revised to $8. This represents a 55.38% premium over Thursday’s closing price.

Analyzing GOVX’s Price Performance

On Thursday, GeoVax Labs Inc. [NASDAQ: GOVX] rose 30.29% to $3.57. The stock’s lowest price that day was $2.25, but it reached a high of $3.90 in the same session. During the last five days, there has been a surge of approximately 79.40%. Over the course of the year, GeoVax Labs Inc. shares have dropped approximately -1.38%. Shares of the company reached a 52-week high of $4.30 on 08/01/22 and a 52-week low of $0.55 on 05/12/22. A 50-day SMA is recorded $1.47, while a 200-day SMA reached $2.22. Nevertheless, trading volume fell to 78.31 million shares from 43.93 million shares the previous day.

Support And Resistance Levels for GeoVax Labs Inc. (GOVX)

According to the 24-hour chart, there is a support level at 2.58, which, if violated, would cause prices to drop to 1.59. In the upper region, resistance lies at 4.23. The next price resistance is at 4.89. RSI (Relative Strength Index) is 71.40 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.23, which suggests the price will increase in the coming days. Percent R is at 19.84%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is GeoVax Labs Inc. subject to short interest?

Stocks of GeoVax Labs Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.24 million shares to 0.1 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 0.34 million shares. A decline of -238.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 0.05 of the overall float, the days-to-cover ratio (short ratio) decline to 0.05.

Which companies own the most shares of GeoVax Labs Inc. (GOVX)?

According to Armistice Capital LLC filings, the company currently owns 435,150 shares, which is about 3.47% of the total GOVX shares outstanding. With the completion of the sale transaction, The Vanguard Group, Inc.’s stake is now worth $212,666. Cavalry Fund I Management LLC reduced a -9.60% interest valued at $0.18 million while Geode Capital Management LLC sold a 0 stake. A total of 49,684 shares of GeoVax Labs Inc. were sold by Virtu Financial BD LLC during the quarter, and 27,323 by Two Sigma Investments LP. In its current portfolio, Dimensional Fund Advisors LP holds 24,062 shares valued at $19971.0.

In terms of GeoVax Labs Inc. share price expectations, FactSet research, analysts set an average price target of $6.00 in the next 12 months, up nearly 118.98% from the previous closing price of $2.74. Analysts anticipate GeoVax Labs Inc. stock to reach $6.00 by 2022, with the lowest price target being $6.00. In spite of this, 1 analysts ranked GeoVax Labs Inc. stock as a Buy at the end of 2022.


Please enter your comment!
Please enter your name here